GE HealthCare Technologies Inc. GEHC
NASDAQ · Healthcare · Medical - Devices
$80.64
Close on Fri, 20 Nov 2026 · market value $36.5B
What the price is betting on
Below its recordAt $81, the price assumes revenue grows about 2.2% a year for five years, from $21.6B to about $23.7B by FY2030. That is less than what analysts expect for the next two years and less than the company's own last three years.
Revenue growth a year. The price figure comes from a reverse DCF at a 8.2% discount rate.
Track it and Parra checks each report against the path, and tells you when revenue falls behind it.
Own more than GEHC? Check up to 5 of your stocks at once, free, no account.
Both sides
Three stories, three values
Bear
$85
Base
$95
Bull
$106
Today $81
- Bear $85. Cash flow grows 3% a year for the next 5 years, slower than expected, then slows to long-run growth.
- Base $95. Cash flow grows 5% a year for the next 5 years, as analysts expect, then slows to long-run growth.
- Bull $106. Cash flow grows 7% a year for the next 5 years, faster than expected, then slows to long-run growth.
Stories set by rules from the company’s record.
Checkpoints
The revenue the price needs
- YearNeedsAnalysts expect
- FY2026$21.8B$21.9B, on the path
- FY2027$22.2B$22.9B, on the path
- FY2028$22.7B$24.1B, on the path
- FY2029$23.2B$25.6B, on the path
- FY2030$23.7B$26.9B, on the path
Each year's revenue at 2.2% growth from $21.6B in the 12 months to September 2026.
At a glance
Healthcare · Medical - Devices · listed on NASDAQ
- Revenue, FY2025
- $20.6B
- Growth, 3 years a year
- 3.8%
- Cash margin
- 7.3%
- Net debt
- $5.5B
- Shares, 3-year change
- +1.4%
- Dividend yield
- 0.2%
What other healthcare prices are betting on
Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.